Current stage?-Stage III - Page 14 of 33 Posts on Medivizor
Navigation Menu

Current stage?-Stage III Posts on Medivizor

Bevacizumab with chemotherapy as a third-line treatment for recurrent/metastatic breast cancer

Bevacizumab with chemotherapy as a third-line treatment for recurrent/metastatic breast cancer

Posted by on Dec 24, 2016 in Breast cancer | 0 comments

In a nutshell This study investigated the long-term effectiveness bevacizumab (Avastin) with chemotherapy for HER2-negative locally recurrent/metastatic breast cancer. This study concluded that while bevacizumab combined with chemotherapy significantly improved time to disease progression compared with chemotherapy alone in the first two phases...

Read More

Is there a benefit of radiation to lymph node metastases during hormone therapy?

Is there a benefit of radiation to lymph node metastases during hormone therapy?

Posted by on Dec 12, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the benefit of radiation to limited sites of cancer spread (metastases) in men no longer responding to hormone therapy. Researchers reported effective local cancer control after radiation of lymph node metastases in patients no longer responding to hormone therapy.  Some background Hormone therapy is the...

Read More

Examining surgery as a primary treatment for high-risk prostate cancer

Examining surgery as a primary treatment for high-risk prostate cancer

Posted by on Dec 12, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined evidence for the role of prostate surgery in treating high-risk prostate cancer. Authors concluded that surgery is an effective primary treatment option for men with high-risk disease. Some background Localized prostate cancer is cancer that is confined to the prostate gland. Men with high-risk localized prostate...

Read More

Should immunotherapy be administered before or after hormone therapy?

Should immunotherapy be administered before or after hormone therapy?

Posted by on Dec 12, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined whether immunotherapy with sipuleucel-T (Provenge) shows a greater immune response if administered before or after androgen deprivation therapy (ADT). Authors present preliminary evidence of improved immune cell response when sipuleucel-T was administered first in patients with recurrent prostate cancer at high risk of...

Read More

High-risk prostate cancer: Is there a survival benefit when chemotherapy is administered before surgery?

High-risk prostate cancer: Is there a survival benefit when chemotherapy is administered before surgery?

Posted by on Nov 28, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the benefit of administering chemotherapy before prostate surgery in men with intermediate- to high-risk prostate cancer. Researchers reported preliminary evidence of a cancer-specific survival benefit when chemotherapy was administered before surgery. Some background Prostate surgery is a first-line treatment for...

Read More

Pre-surgery chemotherapy and radiation therapy improves the outcomes of locally advanced rectal cancer

Pre-surgery chemotherapy and radiation therapy improves the outcomes of locally advanced rectal cancer

Posted by on Nov 14, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the benefits of pre-surgery chemotherapy and radiation therapy (CRT) in patients with rectal cancer and pelvic lymph node metastasis (spread of cancer). Researchers suggested that CRT may have a beneficial impact in the disease outcomes of these patients.   Some background CRT followed by surgery is the...

Read More

Prognostic factors for stage 3b melanoma outcomes

Prognostic factors for stage 3b melanoma outcomes

Posted by on Oct 29, 2016 in Melanoma | 0 comments

In a nutshell This study investigated the predictive factors for the outcomes of stage 3b melanoma. Researchers suggested that patients older than 50 years old, with tumors thicker than 2 mm and positive pelvic lymph nodes are more at risk of death by stage 3b melanoma.  Some background The incidence of melanoma has been rising worldwide....

Read More

10 years on: Comparing treatment options for localized prostate cancer

10 years on: Comparing treatment options for localized prostate cancer

Posted by on Oct 24, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared the effectiveness of different treatment options available for localized prostate cancer. Authors reported low rates of prostate cancer-specific mortality across all treatment groups. However, surgery and radiation therapy were associated with a lower rate of disease progression and metastases compared to active...

Read More

Granulocyte-macrophage colony-stimulating factor (GM-CSF) with melanoma vaccine combined treatment does not improve survival in advanced melanoma

Granulocyte-macrophage colony-stimulating factor (GM-CSF) with melanoma vaccine combined treatment does not improve survival in advanced melanoma

Posted by on Oct 17, 2016 in Melanoma | 0 comments

In a nutshell This study investigated the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) and peptide vaccination (PV) on survival of patients with advanced melanoma. Researchers suggested that neither GM-CSF nor PV were associated with improved survival. Some background GM-CSF stimulates the immune system to produce more...

Read More